Literature DB >> 172950

Experimental immunosuppression induced by herpes simplex virus.

R Cappel, C Henry, L Thiry.   

Abstract

Cell-mediated immune response was studied in experimental herpetic infection in mice. Our data suggest that herpes simplex virus induced immunosuppression in mice. This depression was documented by the unresponsiveness of the lymphocytes to PHA stimulation in vitro and by the enhanced susceptibility of adult mice to Coxsackie B virus infection. Our data also suggest that levamisole, a potent immunostimulant drug, had no effect on the unresponsiveness of the lymphocytes to PHA stimulation.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 172950     DOI： 10.1007/bf02175597

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  15 in total

1.  Cell mediated immunity in experimental rubella infections.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.

Authors:  S Sprecher-Goldberger; L Thiry; I Gould; Y Fassin; C Gompel
Journal:  Am J Epidemiol       Date:  1973-02       Impact factor: 4.897

3.  Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity.

Authors:  R J Howard; J Miller; J S Najarian
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

4.  Letter: Levamisole for recurrent herpes labialis.

Authors:  A Kint; L Verlinden
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

5.  Letter: Viral-antibody detection by a more sensitive complement-fixation reaction.

Authors:  G Zissis; G Clinet
Journal:  Lancet       Date:  1974-04-20       Impact factor: 79.321

6.  The splenic suppressor cell. I. Activity of thymus-dependent adherent cells: changes with age and stress.

Authors:  H Folch; B H Waksman
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

7.  A micro-mixed leukocyte culture technique using whole blood.

Authors:  G D Stockman; D M Mumford; J R Wilbur
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

8.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

9.  A 51 Cr microassay technique for cell-mediated immunity to viruses.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

10.  Immunosuppression during influenza virus infection.

Authors:  G B Kantzler; S F Lauteria; C L Cusumano; J D Lee; R Ganguly; R H Waldman
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441
View more
  6 in total

1.  Efficacy and immune response to rubella subunits vaccines.

Authors:  R Cappel; F De Cuyper
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

2.  Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

3.  Pathogenetic mechansims of recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  Suppression of humoral antibody formation against sheep red blood cells by infections with HSV-2 and the influence of mouse cytomegalovirus. Brief report.

Authors:  S Nick; B Metzger; S Jonsić; D Falke
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Efficacy of a nucleic acid free herpetic subunit vaccine.

Authors:  R Cappel; F de Cuyper; F Rickaert
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

6.  [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].

Authors:  R Jarisch; I Sandor
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.